Takeda Sues Mylan Over Generic Acid Reflux Drug
Takeda Pharmaceutical Co. Ltd. on Wednesday sued rival Mylan Inc. in California federal court, alleging that planned generic versions of acid reflux drug Dexilant infringe multiple patents....To view the full article, register now.
Already a subscriber? Click here to view full article